MedPath

Measurement of Choroidal Thickness in the eyes of Systemic Lupus Erythematosus Patients

Not Applicable
Conditions
Health Condition 1: D899- Disorder involving the immune mechanism, unspecified
Registration Number
CTRI/2023/01/048801
Lead Sponsor
Dr Smriti Choudhary
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All Patients with diagnosis of Systemic Lupus Erythematosus visiting the Department of Ophthalmology and rheumatology Department of Medicine at Kasturba Hospital, Manipal.

Exclusion Criteria

Patients with other retinal diseases and systemic diseases which can affect the choroidal vasculature and choroidal thickness, Pregnant SLE patients.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the choroidal thickness in SLE patients using SD-OCT and <br/ ><br>correlate it with SLE disease activity.Timepoint: 6 monthly (20/06/2023, 20/12/2023, 20/06/2024, 20/12/2024)
Secondary Outcome Measures
NameTimeMethod
To correlate choroidal thickness in SLE patients with SLE Disease Activity Index, Hypertension, Lupus Nephritis, Treatment with Hydroxychloroquine, Treatment with Corticosteroid.Timepoint: 6 monthly (20/06/2023, 20/12/2023, 20/06/2024, 20/12/2024)
© Copyright 2025. All Rights Reserved by MedPath